News

Published on 26 Oct 2022 on Zacks via Yahoo Finance

Glaukos (GKOS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?


Article preview image

Wall Street expects a year-over-year decline in earnings on lower revenues when Glaukos (GKOS) reports results for the quarter ended September 2022. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on November 2. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

NYSE.GKOS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst - Glaukos...

Thursday, Glaukos Corporation GKOS reported a first-quarter adjusted EPS loss of $(0.70), up from...

Benzinga 3 May 2024

Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y

Glaukos Corporation GKOS reported first-quarter 2024 adjusted loss of 70 cents per share, which i...

Zacks via Yahoo Finance 3 May 2024

Glaukos stock price target raised on strong Q1 sales By Investing.com

On Thursday, Glaukos Corporation (NYSE:GKOS) received an updated stock price target from Needham,...

Investing.com 3 May 2024

Can the 4 Medical Device Stocks Hit Targets This Earnings Season?

The earnings season for the Medical sector (one of the 16 broad Zacks sectors within the Zacks In...

Zacks via Yahoo Finance 1 May 2024

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 15 Apr 2024

Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally?

Glaukos GKOS is witnessing strong momentum, with its shares having rallied 24.8% year to date com...

Zacks via Yahoo Finance 12 Apr 2024

Is Now The Time To Look At Buying Glaukos Corporation (NYSE:GKOS)?

While Glaukos Corporation (NYSE:GKOS) might not have the largest market cap around , it received ...

Simply Wall St. via Yahoo Finance 11 Apr 2024

Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock?

Shares of Glaukos Corporation GKOS scaled a new 52-week high of $97.77 on Apr 5, before closing t...

Zacks via Yahoo Finance 8 Apr 2024

Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Glaukos (GKOS). Shares have lost about 4.3...

Zacks via Yahoo Finance 22 Mar 2024

Here's Why You Should Retain Glaukos (GKOS) Stock for Now

Glaukos Corporation GKOS is well-poised for growth on the back of favorable clinical trial result...

Zacks via Yahoo Finance 13 Mar 2024